Piper Jaffray analyst Sarah James reiterated a Buy rating on WellCare Health Plans (NYSE: WCG) yesterday and set a price target of $293. The company’s shares opened today at $269.92, close to its 52-week high of $271.88.
According to TipRanks.com, James is a 5-star analyst with an average return of 23.1% and a 90.8% success rate. James covers the Services sector, focusing on stocks such as Encompass Health Corporation, Molina Healthcare, and Community Health.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for WellCare Health Plans with a $285 average price target, implying a 5.6% upside from current levels. In a report issued on July 23, Barclays also initiated coverage with a Buy rating on the stock with a $288 price target.
.
See today’s analyst top recommended stocks >>
The company has a one-year high of $271.88 and a one-year low of $162.25. Currently, WellCare Health Plans has an average volume of 313.5K.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
WellCare Health Plans, Inc. engages in the provision of government-sponsored managed care services through Medicaid, Medicare Advantage, and Medicare Prescription Drug Plans to families, children, seniors, and individuals with complex medical needs. It operates through the following segments: Medicaid Health Plans, Medicare Health Plans, and Medicare PDPs.
